![Isaac Kobrin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Isaac Kobrin
No open positions remaining
Profile
Isaac Kobrin was the founder of TOLREMO therapeutics AG, serving as Director since 2017.
Former jobs include Executive Chairman at Novaremed AG from 2017 to 2024, Director at SciSparc Ltd., Director at Proteomedix AG, Director at Immune Pharmaceuticals, Inc. from 2013 to 2014, Director at Virometix AG, Leader-Cardiovascular Clinical Development Group at F.
Hoffmann-La Roche Ltd. in 1999, Chief Medical Officer & Senior Vice President at Actelion Ltd. from 2009 to 2012, and Senior Physician & Lecturer-Internal Medicine at Hadassah University Hospital.
Education includes a doctorate from The Hebrew University of Jerusalem and a graduate degree from The Hebrew University Hadassah Medical School.
Former positions of Isaac Kobrin
| Companies | Position | End |
|---|---|---|
Novaremed AG
 Novaremed AG Pharmaceuticals: MajorHealth Technology Develops safer and more efficacious drugs for chronic and life-threatening diseases | Chairman | 01/01/2024 |
| IMMUNE PHARMACEUTICALS, INC. | Director/Board Member | 10/06/2014 |
| ACTELION | Chief Tech/Sci/R&D Officer | 31/01/2012 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/1999 |
Virometix AG
 Virometix AG BiotechnologyHealth Technology Operates as biotechnology company which develops vaccines and immunotherapeutic drugs for prevention, treatment of infectious & chronic human diseases | Director/Board Member | - |
Training of Isaac Kobrin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
57
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs | Health Technology |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hadassah University Hospital
 Hadassah University Hospital Hospital/Nursing ManagementHealth Services Operates hospitals and universities | Health Services |
SciSparc Ltd.
 SciSparc Ltd. Pharmaceuticals: MajorHealth Technology Develops innovative vaccines and immunotherapy products | Health Technology |
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Develops safer and more efficacious drugs for chronic and life-threatening diseases | Health Technology |
Proteomedix AG
 Proteomedix AG BiotechnologyHealth Technology Operates as a private, commercial-stage diagnostics oncology company | Health Technology |
Immune Pharmaceuticals, Inc.
 Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
The Hebrew University Hadassah Medical School
 The Hebrew University Hadassah Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virometix AG
Virometix AG BiotechnologyHealth Technology Operates as biotechnology company which develops vaccines and immunotherapeutic drugs for prevention, treatment of infectious & chronic human diseases | Health Technology |
TOLREMO therapeutics AG
 TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services Develops and delivers therapies for treating cancer patients | Commercial Services |
- Stock Market
- Insiders
- Isaac Kobrin
